GOTHENBURG, SE / ACCESS Newswire / January 23, 2025 /IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, January ...
Y es, Parkinson's is a disease that effects nerve cells in the brain, leading to tremors, stiffness, speech changes and more, ...
A novel wireless photothermal DBS nanosystem uses nanoparticles to target and restore damaged neurons in Parkinson’s disease, ...
Researchers in China discovered that an injection of nanoparticles into the brain could reverse the symptoms of Parkinson's ...
Yulan Xiong, associate professor of neuroscience at UConn Health, and her team have discovered one more piece of the puzzle ...
9don MSNOpinion
Parkinson's disease is a solvable problem, but only if we act decisively and urgently. We have the knowledge, and we've built ...
GOTHENBURG, SE / ACCESS Newswire / January 23, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, January 23, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company dis ...
ScienceAlert on MSN3d
Parkinson's Discovery Suggests We Could Already Have an FDA-Approved TreatmentParkinson's symptoms mainly result from the death or impairment of dopamine-producing neurons in the brain's substantia nigra ...
Laredo Morning Times on MSN12h
Laredo Parkinson’s Support Group to host expert speaker on sleep, Parkinson’sLaredo Parkinson’s Support Group will host UT Health San Antonio’s Dr. Eleni Vaou speaking on sleep and Parkinson’s at its ...
Learn how caffeine affects Parkinson's disease prevention and treatment. New research uncovers both protective benefits and ...
GlobalData on MSN8d
BlueRock accelerates Parkinson’s disease therapy to Phase IIIThe US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...
Hearing impairment is a risk factor for incident Parkinson disease (PD), according to a study published online in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback